Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
American Journal of Cancer Research|August 4, 2012
When autophagy meets cancer through p62/SQSTM1Alexandre Puissant, Nina Fenouille, Patrick AubergerOncogenesis|May 7, 2026
Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapyNina Fenouille, Camille Lobry, Lina Benajiba, et al.Trends in Cancer|January 3, 2026
Exploiting tumor lineage features for precision cancer therapyLois M Kelly, Nina Fenouille, Kris C Wood, et al.Essays in Biochemistry|December 14, 2017
To be or not to be cell autonomous? Autophagy says bothNina Fenouille, Anna Chiara Nascimbeni, Joëlle Botti-Millet, et al.Cancer Research|January 28, 2010
Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activationAlexandre Puissant, Guillaume Robert, Nina Fenouille, et al.Pigment Cell & Melanoma Research|October 20, 2010
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progressionNina Fenouille, Guillaume Robert, Mélanie Tichet, et al.Cell Cycle (Georgetown, Tex.)|November 22, 2011
Mechanism of action of the multikinase inhibitor ForetinibMaeva Dufies, Arnaud Jacquel, Guillaume Robert, et al.The Journal of Pathology|November 10, 2011
Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenograftsNina Fenouille, Sebastien Grosso, Su Yunchao, et al.Cancer Research|March 19, 2009
Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrestOlivier Bailet, Nina Fenouille, Patricia Abbe, et al.Cancer Research|November 25, 2010
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARCNina Fenouille, Alexandre Puissant, Maeva Dufies, et al.Pageof 3